Kalbe Farma

Indonesian pharmaceutical, healthcare and nutrition company

You can help expand this article with text translated from the corresponding article in Indonesian. (January 2024) Click [show] for important translation instructions.

Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Consider adding a topic to this template: there are already 290 articles in the main category, and specifying|topic= will aid in categorization.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Indonesian Wikipedia article at [[:id:Kalbe Farma]]; see its history for attribution.
You may also add the template {{Translated|id|Kalbe Farma}} to the talk page.
For more guidance, see Wikipedia:Translation.

Pharmaceuticals
Healthcare

Founded10 September 1966; 57 years ago (1966-09-10)HeadquartersJakarta, Indonesia

Area served

Worldwide

Key people

Vidjongtius (CEO)
Bernadette Ruth Irawati Setiady (President)ProductsDrugs, energy drinks, milk, baby food, healthy drinks, herbal supplements and nutrition productsRevenue

Rp 26.261 trillion (2021)

Net income

Rp 3.208 trillion (2021)Total assets

Rp 25.667 trillion (2021)Total equity

Rp 21.365 trillion (2021)

Number of employees

16,235 (2021)Subsidiaries

Bintang Toedjoe
Kalbe Nutritionals
Kalbe Genexine Biologics
Innogene Kalbiotech
Bifarma Adiluhung
Kalbe International
Innolab Sains Internasional
Pharma Metric Labs
Saka Farma Laboratories
Dankos Farma
Hexpharm Jaya Laboratories
Hale International
Finusolprima Farma Internasional
Kalbe Milko Indonesia
Enseval Putera
Indogravure
Kalbe Morinaga
Kalbe Vision

Websitehttps://www.kalbe.co.id/

PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966.^{[citation needed]} The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise. The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol (sold under the brand name of Invitec), a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient (abortion-inducing substance).^[1]

Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.^{[citation needed]}

Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion.

History

Kalbe Farma was founded on September 10, 1966, by 6 siblings, K.L. Tjoen, Theresia H. Setiady, Khouw Lip Swan, Khouw Lip Boen (Also Known As: Dr. Boenyamin Setiawan), Maria Karmila, and F. Bing Aryanto. Kalbe Farma first began operations in a house garage that was owned by the founders.

In May 2020, Kalbe Farma signed a Memorandum of Understanding with South Korean pharmaceuticals company Genexine Inc. to develop a vaccine for the new corona virus or COVID-19.^[2]

References

^ Grafton-Green, Patrick (1 October 2017). "Anti-abortion MP Jacob Rees-Mogg admits profits from abortion pills". Evening Standard. Retrieved 25 March 2020.
^ "Kalbe Farma and South Korea's Genexine to Start Human Trial for Covid-19 Vaccine". Jakarta Globe. Retrieved 2020-09-06.